Frazier Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.9K Sell
2,529
-30
-1% -$785 0.03% 167
2026
Q1
$71.8K Buy
2,559
+1,652
+182% +$44K 0.04% 146
2025
Q4
$22.6K Sell
907
-251
-22% -$6.33K 0.01% 260
2025
Q3
$29.5K Buy
1,158
+4
+0.3% +$99 0.02% 221
2025
Q2
$28K Sell
1,154
-5
-0.4% -$117 0.02% 214
2025
Q1
$29.4K Sell
1,159
-250
-18% -$6.54K 0.02% 201
2024
Q4
$37.2K Sell
1,409
-108
-7% -$2.93K 0.03% 168
2024
Q3
$43.9K Buy
1,517
+239
+19% +$6.97K 0.03% 152
2024
Q2
$35.8K Sell
1,278
-236
-16% -$6.5K 0.03% 196
2024
Q1
$42K Sell
1,514
-311
-17% -$8.63K 0.03% 166
2023
Q4
$52.5K Buy
+1,825
New +$55.2K 0.05% 134

Other funds holding PFE

Frazier Financial Advisors's PFE Position: Q2 2026 in Review

Frazier Financial Advisors reduced its Pfizer (PFE) stake by 1.2% in Q2 2026, selling an estimated $785 and leaving 2,529 shares worth $60.9K. The position accounts for 0.03% of the portfolio, ranked #167.

Frazier Financial Advisors first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $71.8K in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Frazier Financial Advisors held 2,529 shares of Pfizer worth $60.9K as of Q2 2026.
  • Frazier Financial Advisors sold 30 Pfizer shares in Q2 2026, an estimated $785.
  • Pfizer made up 0.03% of Frazier Financial Advisors's portfolio in Q2 2026, its #167 holding.
  • Frazier Financial Advisors first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Frazier Financial Advisors's Pfizer position peaked at $71.8K in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Frazier Financial Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.